Yingkuan Liang

741 total citations
25 papers, 503 citations indexed

About

Yingkuan Liang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yingkuan Liang has authored 25 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Yingkuan Liang's work include Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Yingkuan Liang is often cited by papers focused on Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Yingkuan Liang collaborates with scholars based in China, United States and Taiwan. Yingkuan Liang's co-authors include Feng Jiang, Qixing Mao, Gaochao Dong, Bing Chen, Wenjie Xia, Xuming Song, Lin Xu, Hui Wang, Te Zhang and Te Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yingkuan Liang

23 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingkuan Liang China 12 371 238 110 85 58 25 503
Weimin Mao China 12 335 0.9× 272 1.1× 93 0.8× 126 1.5× 29 0.5× 28 558
Chunlai Lu China 7 381 1.0× 192 0.8× 86 0.8× 132 1.6× 39 0.7× 9 487
Qiliang Peng China 13 260 0.7× 268 1.1× 126 1.1× 93 1.1× 30 0.5× 43 466
Liwen Zhang China 12 311 0.8× 257 1.1× 83 0.8× 48 0.6× 69 1.2× 25 509
Xianli He China 10 242 0.7× 143 0.6× 142 1.3× 96 1.1× 37 0.6× 19 469
Qiaoliang Zhu China 11 382 1.0× 201 0.8× 127 1.2× 147 1.7× 106 1.8× 21 585
Evan R. Abt United States 7 466 1.3× 270 1.1× 171 1.6× 89 1.0× 40 0.7× 15 587
Dongmei Lin China 12 376 1.0× 212 0.9× 173 1.6× 121 1.4× 25 0.4× 31 569
Peizhun Du China 9 383 1.0× 364 1.5× 111 1.0× 68 0.8× 33 0.6× 12 539

Countries citing papers authored by Yingkuan Liang

Since Specialization
Citations

This map shows the geographic impact of Yingkuan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingkuan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingkuan Liang more than expected).

Fields of papers citing papers by Yingkuan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingkuan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingkuan Liang. The network helps show where Yingkuan Liang may publish in the future.

Co-authorship network of co-authors of Yingkuan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yingkuan Liang. A scholar is included among the top collaborators of Yingkuan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingkuan Liang. Yingkuan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Yingkuan, et al.. (2025). Comparison of SGLT2 and DPP4 inhibitors on clinical outcomes in COPD patients with diabetes: A nationwide cohort study. Diabetes Research and Clinical Practice. 223. 112122–112122. 5 indexed citations
2.
Tan, Hongwei, et al.. (2025). Impact of selenium status and supplementation on outcomes in critically ill patients. Scientific Reports. 15(1). 35478–35478.
3.
Chen, Yuzhong, Xuming Song, Yingkuan Liang, et al.. (2024). Ferritinophagy mediates adaptive resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Nature Communications. 15(1). 4195–4195. 12 indexed citations
4.
Huang, Haitao, Na Li, Yingkuan Liang, et al.. (2023). Multi‐omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma. Clinical and Translational Medicine. 13(11). e1493–e1493. 8 indexed citations
5.
Wang, Hui, Yingkuan Liang, Te Zhang, et al.. (2023). C-IGF1R encoded by cIGF1R acts as a molecular switch to restrict mitophagy of drug-tolerant persister tumour cells in non-small cell lung cancer. Cell Death and Differentiation. 30(11). 2365–2381. 16 indexed citations
6.
Wang, Hui, Xuming Song, Te Zhang, et al.. (2023). Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy. Journal for ImmunoTherapy of Cancer. 11(6). e006939–e006939. 15 indexed citations
7.
Dong, Gaochao, Yingkuan Liang, Bing Chen, et al.. (2023). N6‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma. Thoracic Cancer. 14(29). 2962–2975. 7 indexed citations
8.
Song, Xuming, Te Zhang, Bing Chen, et al.. (2022). Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype. Oncogenesis. 11(1). 61–61. 5 indexed citations
9.
Zhang, Te, Wenjie Xia, Xuming Song, et al.. (2022). Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway. Journal of Hematology & Oncology. 15(1). 114–114. 45 indexed citations
10.
Chen, Fang, Yingkuan Liang, Yong Huang, et al.. (2022). P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR. Cancers. 14(13). 3243–3243. 2 indexed citations
11.
Liang, Yingkuan, Nan Wang, Yijian Zhang, et al.. (2022). Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC. Cell Death and Disease. 13(10). 873–873. 4 indexed citations
12.
Huang, Xing, Yingkuan Liang, Te Zhang, et al.. (2022). Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma. The Journal of Pathology Clinical Research. 8(5). 422–435. 28 indexed citations
13.
Zhang, Yi, Qi Wang, Xuming Song, et al.. (2021). A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma. BMC Cancer. 21(1). 1098–1098. 11 indexed citations
14.
Mao, Qixing, Lin Wang, Yingkuan Liang, et al.. (2020). CYP3A5 suppresses metastasis of lung adenocarcinoma through ATOH8/Smad1 axis.. PubMed. 10(10). 3194–3211. 5 indexed citations
15.
Liang, Yingkuan, Wenjie Xia, Te Zhang, et al.. (2020). Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma. Frontiers in Oncology. 10. 573534–573534. 40 indexed citations
16.
Liang, Yingkuan, Hui Wang, Bing Chen, et al.. (2020). circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression. Molecular Therapy — Nucleic Acids. 23. 355–368. 105 indexed citations
17.
Wang, Hui, Xuming Song, Yajing Wang, et al.. (2020). CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma. Cell Death and Disease. 11(11). 1010–1010. 17 indexed citations
18.
Xia, Wenjie, Qixing Mao, Bing Chen, et al.. (2019). The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma. Oncogenesis. 8(11). 62–62. 20 indexed citations
19.
Wang, Lin, Yingkuan Liang, Qixing Mao, et al.. (2019). Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)‐182/miR‐93‐leukemia inhibitory factor receptor pathway. Cancer Science. 110(9). 2960–2972. 66 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weimin Mao Breakdown of academic impact, for papers by Chunlai Lu Breakdown of academic impact, for papers by Qiliang Peng Breakdown of academic impact, for papers by Liwen Zhang Breakdown of academic impact, for papers by Xianli He Breakdown of academic impact, for papers by Qiaoliang Zhu Breakdown of academic impact, for papers by Evan R. Abt Breakdown of academic impact, for papers by Dongmei Lin Breakdown of academic impact, for papers by Peizhun Du
Rankless by CCL
2026